Literature DB >> 8740155

Comparison of the densities of 5-HT4 receptors, beta 1- and beta 2-adrenoceptors in human atrium: functional implications.

A J Kaumann1, J A Lynham, A M Brown.   

Abstract

We measured in human atrium the density of 5-HT4 receptors, labelled with [125I]-SB 207710 (1-butyl-4-piperidinyl) methyl 8-amino-7-iodo-1, 4-benzodioxan-5-carboxylate), and compared it with the density of beta1- and beta2-adrenoceptors, labelled with (-)-[125I]-cyanopindolol. [125I]-SB 207710 (5-1200 pmol/l) labelled a small population of saturable binding sites (Bmax approximately 4 fmol/mg protein) with a pK(D) of 9.7 and with 5-HT4 receptor characteristics, as assessed with competing ligands. The density of atrial binding sites with 5-HT4 receptor characteristics was 10 and 5 times lower, respectively, than the density of beta 1- and beta 2-adrenoceptors. We suggest that the small 5-HT4 receptor population may in part explain why the positive inotropic effects of 5-HT are smaller than those of catecholamines mediated through beta 1- and beta 2-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8740155     DOI: 10.1007/bf00169181

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  20 in total

1.  CGP 20712 A: a useful tool for quantitating beta 1- and beta 2-adrenoceptors.

Authors:  D J Dooley; H Bittiger; N C Reymann
Journal:  Eur J Pharmacol       Date:  1986-10-14       Impact factor: 4.432

2.  Labelling with [125I]-SB 207710 of a small 5-HT4 receptor population in piglet right atrium: functional relevance.

Authors:  A J Kaumann; J A Lynham; A M Brown
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

3.  Binding characteristics of (+)-, (+/-)- and (-)-[125iodo] cyanopindolol to guinea-pig left ventricle membranes.

Authors:  D Hoyer; G Engel; R Berthold
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-03       Impact factor: 3.000

4.  A 5-hydroxytryptamine receptor in human atrium.

Authors:  A J Kaumann; L Sanders; A M Brown; K J Murray; M J Brown
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

5.  The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons.

Authors:  A Dumuis; M Sebben; J Bockaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

6.  Identification and characterization of serotonin 5-HT4 receptor binding sites in human brain: comparison with other mammalian species.

Authors:  T Doménech; J Beleta; A G Fernández; R W Gristwood; F Cruz Sánchez; E Tolosa; J M Palacios
Journal:  Brain Res Mol Brain Res       Date:  1994-01

7.  Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain.

Authors:  C J Grossman; G J Kilpatrick; K T Bunce
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

8.  A 5-HT4-like receptor in human left atrium.

Authors:  L Sanders; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

9.  Sensitization of human atrial 5-HT4 receptors by chronic beta-blocker treatment.

Authors:  L Sanders; J A Lynham; B Bond; F del Monte; S E Harding; A J Kaumann
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

10.  Blockade of human atrial 5-HT4 receptors by SB 207710, a selective and high affinity 5-HT4 receptor antagonist.

Authors:  A J Kaumann; L M Gaster; F D King; A M Brown
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-05       Impact factor: 3.000

View more
  16 in total

1.  Isolation of the serotoninergic 5-HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines.

Authors:  J Mialet; I Berque-Bestel; P Eftekhari; M Gastineau; M Giner; Y Dahmoune; P Donzeau-Gouge; J Hoebeke; M Langlois; S Sicsic; R Fischmeister; F Lezoualc'h
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

2.  Pharmacological characterization of the human 5-HT(4(d)) receptor splice variant stably expressed in Chinese hamster ovary cells.

Authors:  J Mialet; I Berque-Bestel; S Sicsic; M Langlois; R Fischmeister; F Lezoualc'h
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

3.  Treatment functional GI disease: the complex pharmacology of serotonergic drugs.

Authors:  Fabrizio De Ponti; Francesca Crema
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

4.  Functional studies of the 5'-untranslated region of human 5-HT4 receptor mRNA.

Authors:  Marjorie Maillet; Monique Gastineau; Pascal Bochet; Marie-Liesse Asselin-Labat; Eric Morel; Jean-Noël Laverrière; Anne-Marie Lompré; Rodolphe Fischmeister; Frank Lezoualc'h
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

5.  Fading of 5-HT4 receptor-mediated inotropic responses to 5-hydroxytryptamine is caused by phosphodiesterase activity in porcine atrium.

Authors:  Alberto J Kaumann; Finn Olav Levy
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

6.  Selective desensitization of the 5-HT4 receptor-mediated response in pig atrium but not in stomach.

Authors:  J H De Maeyer; J A J Schuurkes; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2009-01-13       Impact factor: 8.739

7.  Arrhythmias, elicited by catecholamines and serotonin, vanish in human chronic atrial fibrillation.

Authors:  Torsten Christ; Nadiia Rozmaritsa; Andreas Engel; Emanuel Berk; Michael Knaut; Katharina Metzner; Manuel Canteras; Ursula Ravens; Alberto Kaumann
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

8.  The effects of serotonin on the electrophysiological properties of atrioventricular node during an experimental atrial fibrillation.

Authors:  Shima Changizi; Vahid Khori; Ali Mohammad Alizadeh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-04-22       Impact factor: 3.000

9.  Cloning, pharmacological characterisation and tissue distribution of a novel 5-HT4 receptor splice variant, 5-HT4(i).

Authors:  Trond Brattelid; Ane M Kvingedal; Kurt A Krobert; Kjetil W Andressen; Trond Bach; Marit E Hystad; Alberto J Kaumann; Finn Olav Levy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-04-30       Impact factor: 3.000

10.  Surprises from a cardiac 5-HT₄TG mouse: spontaneous atrial arrhythmias by endogenous 5-HT of atrial origin? Different mechanism of arrhythmias through 5-HT₄ receptors and β-adrenoceptors?

Authors:  Alberto J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.